(Q38980455)

8 September 2017

title

Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition (English)

1 reference

8 September 2017

1 reference

A B Del Campo

1

1 reference

8 September 2017

J Carretero

2

1 reference

8 September 2017

J A Muñoz

3

1 reference

8 September 2017

S Zinchenko

4

1 reference

8 September 2017

F Ruiz-Cabello

5

1 reference

8 September 2017

G González-Aseguinolaza

6

1 reference

8 September 2017

F Garrido

7

1 reference

8 September 2017

N Aptsiauri

8

1 reference

8 September 2017

publication date

27 June 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

21

1 reference

8 September 2017

issue

8

1 reference

8 September 2017

page(s)

317-332

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2014.32

8 September 2017

exact match

0 references

cites work

MHC class I antigens and immune surveillance in transformed cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Immunotherapeutic strategies for cancer treatment: a novel protein transfer approach for cancer vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

The macromolecular peptide-loading complex in MHC class I-dependent antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Gene therapy clinical trials worldwide to 2012 - an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Adenoviral vector-based strategies for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

MHC class I antigen presentation: learning from viral evasion strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

The MHC class I antigen presentation pathway: strategies for viral immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Identification of class I MHC regions which bind to the adenovirus E3-19k protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

The transmembrane domain of the adenovirus E3/19K protein acts as an endoplasmic reticulum retention signal and contributes to intracellular sequestration of major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Virus Evasion of MHC Class I Molecule Presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Serum beta 2 microglobulin in malignant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Cryopreservation of adenovirus-transfected dendritic cells (DCs) for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Analysis of HLA-ABC locus-specific transcription in normal tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Locus-specific constitutive and cytokine-induced HLA class I gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Expression of histocompatibility antigens H-2K, -D, and -L is reduced in adenovirus-12-transformed mouse cells and is restored by interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Improved treatment of pancreatic cancer by IL-12 and B7.1 costimulation: antitumor efficacy and immunoregulation in a nonimmunogenic tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Tumour immunity and T cell memory are induced by low dose inoculation with a non-replicating adenovirus encoding TAP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Determinants of the endoplasmic reticulum (ER) lumenal-domain of the adenovirus serotype 2 E3-19K protein for association with and ER-retention of major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Control of MHC class I traffic from the endoplasmic reticulum by cellular chaperones and viral anti-chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Tapasin increases efficiency of MHC I assembly in the endoplasmic reticulum but does not affect MHC I stability at the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Overexpression of calreticulin increases intracellular Ca2+ storage and decreases store-operated Ca2+ influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Regulation of autophagy by cytoplasmic p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Serum β2-Microglobulin and Prognosis of Patients with Renal Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2014.32

Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis

21 January 2018

1 reference

12 December 2020

Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression.

1 reference

12 December 2020

"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy

1 reference

12 December 2020

Changes in NF-kappa B and ISGF3 DNA binding activities are responsible for differences in MHC and beta-IFN gene expression in Ad5- versus Ad12-transformed cells

1 reference

12 December 2020

Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice

1 reference

12 December 2020

Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients

1 reference

12 December 2020

Synthesis and turnover of beta2-microglobulin in Ad12-transformed cells defective in assembly and transport of class I major histocompatibility complex molecules

1 reference

12 December 2020

Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action

1 reference

12 December 2020

HLA-B locus-specific downregulation in human melanoma requires enhancer A as well as a sequence element located downstream of the transcription initiation site

1 reference

12 December 2020

Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors

1 reference

12 December 2020

Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance

1 reference

12 December 2020

The 'chop-and-change' of MHC class I assembly

1 reference

12 December 2020

Association of human class I MHC alleles with the adenovirus E3/19K protein

1 reference

12 December 2020

Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.

1 reference

12 December 2020

Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene

1 reference

12 December 2020

Aberrant biosynthesis and transport of class I major histocompatibility complex molecules in cells transformed with highly oncogenic human adenoviruses.

1 reference

12 December 2020

Adenovirus proteins and MHC expression.

1 reference

12 December 2020

An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens

1 reference

12 December 2020

Identifiers

DOI

10.1038/CGT.2014.32

1 reference

8 September 2017

1 reference